Insurance covers standard MS treatments but not stem-cell therapy, which is self-pay. A growing number of registered trials enrol MS patients without charge, particularly in North America and Europe — a route to treatment without payment if the research aligns with your goals.
Indicative European costs are roughly €4,500–€7,500 per course, reflecting manufacturing, sterility testing, and often multiple doses. MS patients usually need MRI before and after, and intrathecal (spinal) delivery may require hospitalisation, raising the total. Established MS disease-modifying therapies cost roughly €800–€3,000 monthly via insurance and are proven — the stem-cell figure is indicative and unproven.
Am I a candidate? → · Multiple Sclerosis: full overview → · Multiple Sclerosis cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
Medicina rigenerativa certificata GMP nel cuore dell'UE — da 3.000–8.000 €, una frazione dei prezzi USA o tedeschi. Protocolli personalizzati per pazienti da oltre 50 Paesi.
Valutazione medica gratuita